This work revealed that the histone demethylase KDM5C regulated the protein stability of CRBN by its non-enzymatic function and that the MLN4924-KDM5C axis increased CRBN, thus potentiating the antileukemia effect of Len, which may provide an alternative combination therapy for AML. Here, KDM5C is linked to acute myeloid leukemia.